NASDAQ · BIOX

Bioceres Crop Solutions Corp.

$0.34 -$0.00 (-1.44%) 1D After hours

Key Metrics

$22.21M
Market cap
P/E · TTM
$286.54M
Revenue · TTM
−$243.17M
Net income
EPS · TTM $-3.81
Dividend yield
Free cash flow
Beta · 1Y 1.74
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 25
    From its Jan 29 high, the share price fell 66%.

    Peak close $0.97 on Jan 29; trough close $0.33 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -66%
  • Mar 2
    The stock moved -18.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 2
  • Feb 3
    The stock moved -32.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$22.21M
Enterprise value
Shares outstanding63.8M
52-wk range$0.30 – $3.84
Avg volume · 20D184.5K
Net cash
Book value / share
ExchangeNASDAQ
About Bioceres Crop Solutions Corp.
IPO dateMar 22, 2018
Employees751

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.08
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net -84.9%
FCF
ROE / ROIC — · —

Financial Health

Current ratio
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings